Literature DB >> 10685726

Increased arginase activity in aorta of mineralocorticoid-salt hypertensive rats.

S Rodriguez1, L Richert, A Berthelot.   

Abstract

The present study was designed, first to investigate aortic arginase activity during the development and the establishment of mineralocorticoid-salt (DOCA-salt) hypertension, and second, to determine the relationship between arginase activity and blood pressure by giving a protein-supplemented diet (50% casein) known to increase hepatic arginase activity. Our results showed that aortic arginase activity in established hypertension of DOCA-salt rats was higher than in normotensive rats. The protein-supplemented diet (50% casein) accelerated the development of DOCA-salt hypertension. There was a positive correlation between arginase activity and the level of blood pressure in these DOCA-salt hypertensive rats fed 50% casein but not in DOCA-salt hypertensive rats on a normal (20% casein) diet. In normotensive rats, the protein-supplemented diet decreased aortic arginase activity and produced no change in systolic blood pressure. Our data suggest that aortic arginase activity is modified in established DOCA-salt hypertension and could participate in the physiopathology of arterial hypertension.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10685726     DOI: 10.1081/ceh-100100063

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  14 in total

Review 1.  Arginase: a critical regulator of nitric oxide synthesis and vascular function.

Authors:  William Durante; Fruzsina K Johnson; Robert A Johnson
Journal:  Clin Exp Pharmacol Physiol       Date:  2007-09       Impact factor: 2.557

2.  Effects of angiotensin type 1 receptor blockade on arginine and ADMA synthesis and metabolic pathways in fawn-hooded hypertensive rats.

Authors:  Gin-Fu Chen; Laszlo Wagner; Jennifer M Sasser; Sergey Zharikov; Natasha C Moningka; Chris Baylis
Journal:  Nephrol Dial Transplant       Date:  2010-05-19       Impact factor: 5.992

3.  Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability.

Authors:  Gustavo H Oliveira-Paula; Fernanda Borchers Coeli-Lacchini; Letícia Perticarrara Ferezin; Graziele C Ferreira; Lucas C Pinheiro; Waynice N Paula-Garcia; Luis V Garcia; Jose E Tanus-Santos; Riccardo Lacchini
Journal:  Eur J Clin Pharmacol       Date:  2021-01-07       Impact factor: 2.953

4.  Insights into the arginine paradox: evidence against the importance of subcellular location of arginase and eNOS.

Authors:  Shawn Elms; Feng Chen; Yusi Wang; Jin Qian; Bardia Askari; Yanfang Yu; Deepesh Pandey; Jennifer Iddings; Ruth B Caldwell; David J R Fulton
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-06-21       Impact factor: 4.733

5.  Urinary albumin-to-creatinine ratio is inversely related to nitric oxide synthesis in young black adults: the African-PREDICT study.

Authors:  Ashleigh Craig; Catharina M C Mels; Aletta E Schutte; Alexander Bollenbach; Dimitrios Tsikas; Edzard Schwedhelm; Ruan Kruger
Journal:  Hypertens Res       Date:  2020-07-17       Impact factor: 3.872

6.  Arginase 1 mediates increased blood pressure and contributes to vascular endothelial dysfunction in deoxycorticosterone acetate-salt hypertension.

Authors:  Haroldo A Toque; Kenia P Nunes; Modesto Rojas; Anil Bhatta; Lin Yao; Zhimin Xu; Maritza J Romero; R Clinton Webb; Ruth B Caldwell; R William Caldwell
Journal:  Front Immunol       Date:  2013-07-29       Impact factor: 7.561

7.  L-arginase induces vascular dysfunction in old spontaneously hypertensive rats.

Authors:  O Arishe; J McKenzie; F Priviero; A B Ebeigbe; R Clinton Webb
Journal:  J Afr Assoc Physiol Sci       Date:  2019-12

8.  Role of arginase in vessel wall remodeling.

Authors:  William Durante
Journal:  Front Immunol       Date:  2013-05-13       Impact factor: 7.561

9.  Vasomotor regulation of coronary microcirculation by oxidative stress: role of arginase.

Authors:  Lih Kuo; Travis W Hein
Journal:  Front Immunol       Date:  2013-08-19       Impact factor: 7.561

Review 10.  Targeting Nitric Oxide with Natural Derived Compounds as a Therapeutic Strategy in Vascular Diseases.

Authors:  Maurizio Forte; Valeria Conti; Antonio Damato; Mariateresa Ambrosio; Annibale A Puca; Sebastiano Sciarretta; Giacomo Frati; Carmine Vecchione; Albino Carrizzo
Journal:  Oxid Med Cell Longev       Date:  2016-08-29       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.